Toggle Main Menu Toggle Search

Open Access padlockePrints

Drug review process advancement and required manufacturer and contract research oraganization responses

Lookup NU author(s): Professor Anne Dickinson

Downloads


Licence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).


Abstract

© 2024 The Japanese Society of Toxicologic Pathology.The United States Senate passed the “FDA Modernization Act 2.0.” on September 29, 2022. Although the effectiveness of this Bill, which aims to eliminate the mandatory use of laboratory animals in new drug development, is limited, it represents a significant trend that will change the shape of drug applications in the United States and other countries. However, pharmaceutical companies have not taken major steps towards the complete elimination of animal testing from the standpoint of product safety, where they prioritize patient safety. Nonetheless, society is becoming increasingly opposed to animal testing, and efforts will be made to use fewer animals and conduct fewer animal tests as a natural and reasonable response. These changes eventually alter the shape of new drug applications. Based on the assumption that fewer animal tests will be conducted or fewer animals will be used in testing, this study explored bioinformatics and new technologies as alternatives to compensate for reduced information and provide a picture of how future new drug applications may look. The authors also discuss the directions that pharmaceutical companies and nonclinical contract research organizations should adopt to promote the replacement, reduction, and refinement of animals used in research, teaching, testing, and exhibitions.


Publication metadata

Author(s): Anzai T, Myatt GJ, Hall F, Finney B, Nakagawa K, Iwata H, Anzai R, Dickinson A, Freer M, Nakae D, Onodera H, Matsuyama T

Publication type: Review

Publication status: Published

Journal: Journal of Toxicologic Pathology

Year: 2024

Volume: 37

Issue: 2

Pages: 45-53

Print publication date: 02/04/2024

Online publication date: 22/11/2023

Acceptance date: 09/11/2023

ISSN (print): 0914-9198

ISSN (electronic): 1881-915X

Publisher: Japanese Society of Toxicologic Pathology

URL: https://doi.org/10.1293/tox.2023-0106

DOI: 10.1293/tox.2023-0106


Share